In this edition, endoscopic hemostasis system cleared by FDA for nonvariceal upper GI bleeding; Infliximab retreatment results in remission in patients with Crohn’s disease; men who have sex with men twice as likely to be diagnosed with IBD and more. Read the full coverage here:
Endoscopic hemostasis system cleared by FDA for nonvariceal upper GI bleeding
Infliximab retreatment results in remission in 35% of patients with Crohn’s disease
Men who have sex with men twice as likely to be diagnosed with IBD
Obeticholic acid yields fewer deaths, liver transplants in primary biliary cholangitis
Third COVID vaccine provides ‘significant boost’ in antibody response in patients with IBD
References:
Alexander JL, et al. Lancet Gastroenterol Hepatol. 2022;doi:10.1016/S2468-1253(22)00274-6.
Boschetti G, et al. Am J Gastroenterol. 2022;doi:10.14309/ajg.0000000000001842.
Mansoor E, et al. Gut. 2022;doi:10.1136/gutjnl-2022-328218.
Murillo Perez CF, et al. Gastroenterology. 2022;doi:10.1053/j.gastro.2022.08.054.
